Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-95
SponsorEmory University
About this trial
This clinical trial aims to determine the effects of a 6-day low-dose methylprednisolone course on pain, nausea, and total opioid consumption in patients undergoing foot and ankle surgeries.
The secondary objective of the study is to determine and monitor the effects of the course on complications following surgery and patient-reported outcomes
Eligibility criteria
Qualifiers
None
Disqualifiers
Concurrent or significant injuries to other bones or organs
Local infections
History of alcohol or medical abuse, including prior opioid abuse
Smoking
Trial design
Treatments tested in this trial
- medrol dosepak
- HYDROcodone Oral Tablet
Treatment groups
180 Participants
are divided into 2 treatment groupsLocations
2Emory Musculoskeletal Institute, Emory Orthopaedics & Spine Center30329, AtlantaGeorgia, United States
Emory Sports Medicine Complex and Emory Orthopaedics and Spine Center30022, Johns CreekGeorgia, United States
Sponsors and collaborators
Emory University
Lead sponsor
Source ClinicalTrials.gov